Quantcast
Home / Practice Areas / Business and Civil Practice / Biotech co. can sue competitor over product claims

Biotech co. can sue competitor over product claims

A biotech company could sue a competitor under the Lanham Act for distributing a press release that allegedly made false claims about a drug both companies manufactured and sold, a U.S. District Court in Massachusetts has ruled.


Lawyers USA has ceased publication. If you have purchased a research pass or still have additional time on your current Digital Subscription, you may access locked stories by logging in:







Scroll To Top